Literature DB >> 7738913

In vivo inhibition of cell-mediated and humoral immune responses to cellular antigens by SV-IV, a major protein secreted from the rat seminal vesicle epithelium.

C Romano-Carratelli1, M Galdiero, I Nuzzo, C Bentivoglio, R Porta, G Peluso, G Ravagnan, S Metafora.   

Abstract

Microgram amounts of protein SV-IV, a major secretory protein produced by adult rat seminal vesicle epithelium, markedly decrease the mouse humoral immune response to cellular xenogeneic or allogeneic antigens (sheep red blood cells (SRBC) or mouse epididymal spermatozoa). The significant reduction in the total number of splenocytes and their main cell subsets in SRBC-immunized mice, the dramatic decrease in the number of Ia+ splenic T cells and the marked inhibition of splenocyte ability to respond in vitro to polyclonal mitogen stimuli suggest that the macrophage accessory cells are the primary target of the SV-IV immunosuppressive activity in vivo. Moreover, the infection of SV-IV-treated mice with Salmonella typhimurium produced an increased mortality of the experimental animals associated with a marked decrease of the phagocytic and intracellular killing activities of their peritoneal macrophages.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738913     DOI: 10.1016/0165-0378(94)00900-r

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  3 in total

1.  The N-terminal 1-16 peptide derived in vivo from protein seminal vesicle protein IV modulates alpha-thrombin activity: potential clinical implications.

Authors:  Marilena Lepretti; Susan Costantini; Gaetano Ammirato; Gaia Giuberti; Michele Caraglia; Angelo M Facchiano; Salvatore Metafora; Paola Stiuso
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

2.  Effect of protein SV-IV on experimental Salmonella enterica serovar Typhimurium infection in mice.

Authors:  Caterina Romano-Carratelli; Concetta Bentivoglio; Immacolata Nuzzo; Nunzia Benedetto; Elisabetta Buommino; Anna Cozzolino; Maria Cartenì; Francesco Morelli; Maria Rosaria Costanza; Biancamaria Metafora; Vittoria Metafora; Salvatore Metafora
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

3.  SV-IV Peptide1-16 reduces coagulant power in normal Factor V and Factor V Leiden.

Authors:  Biagio Di Micco; Marilena Lepretti; Lidia Rota; Ilaria Quaglia; Paola Ferrazzi; Gianluca Di Micco; Pierpaolo Di Micco
Journal:  J Transl Med       Date:  2007-12-21       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.